Skip to content

Clinical trials

Fallopian Tube Neoplasms trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fallopian Tube Neoplasms Country / region: Russia Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20091
20101
20121
20132
20141
20161
20172
20184
20191
20213

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
pharmaand GmbH3
Amgen2
AstraZeneca2
Eli Lilly and Company2
Merck Sharp & Dohme LLC2
Pfizer2
AbbVie1
Glycotope GmbH1
Hoffmann-La Roche1
ImmunoGen, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fallopian Tube Neoplasms19
Ovarian Neoplasms15
Carcinoma, Ovarian Epithelial8
Peritoneal Neoplasms4
Neoplasms2
Breast Neoplasms1
Breast Neoplasms, Male1
Genital Neoplasms, Male1
Pathologic Complete Response1
Prostatic Neoplasms1

Trials

Showing 76 to 19 of 19. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.